Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice

<p>Abstract</p> <p>Background</p> <p>Apert syndrome is characterized by craniosynostosis and limb abnormalities and is primarily caused by FGFR2 +/P253R and +/S252W mutations. The former mutation is present in approximately one third whereas the latter mutation is present in two-thirds of the patients with this condition. We previously reported an inbred transgenic mouse model with the Fgfr2 +/S252W mutation on the C57BL/6J background for Apert syndrome. Here we present a mouse model for the Fgfr2+/P253R mutation.</p> <p>Results</p> <p>We generated inbred <it>Fgfr2</it>^{+/<it>P253R </it>}mice on the same C56BL/6J genetic background and analyzed their skeletal abnormalities. 3D micro-CT scans of the skulls of the <it>Fgfr2</it>^{+/<it>P253R </it>}mice revealed that the skull length was shortened with the length of the anterior cranial base significantly shorter than that of the <it>Fgfr2</it>^{+/<it>S252W </it>}mice at P0. The <it>Fgfr2</it>^{+/<it>P253R </it>}mice presented with synostosis of the coronal suture and proximate fronts with disorganized cellularity in sagittal and lambdoid sutures. Abnormal osteogenesis and proliferation were observed at the developing coronal suture and long bones of the <it>Fgfr2</it>^{+/<it>P253R </it>}mice as in the <it>Fgfr2</it>^{+/<it>S252W </it>}mice. Activation of mitogen-activated protein kinases (MAPK) was observed in the <it>Fgfr2</it>^{+/<it>P253R </it>}neurocranium with an increase in phosphorylated p38 as well as ERK1/2, whereas phosphorylated AKT and PKCα were not obviously changed as compared to those of wild-type controls. There were localized phenotypic and molecular variations among individual embryos with different mutations and among those with the same mutation.</p> <p>Conclusions</p> <p>Our <it>in vivo </it>studies demonstrated that the Fgfr2 +/P253R mutation resulted in mice with cranial features that resemble those of the <it>Fgfr2</it>^{+/<it>S252W </it>}mice and human Apert syndrome. Activated p38 in addition to the ERK1/2 signaling pathways may mediate the mutant neurocranial phenotype. Though Apert syndrome is traditionally thought to be a consistent phenotype, our results suggest localized and regional variations in the phenotypes that characterize Apert syndrome.</p